Vitamin D Supplements: A Reality Check on Who Actually Benefits
Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

Search
60 stories for“DeFi”
Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

Diabetes care is organised around bringing numbers down, which makes it easy to forget that the acute danger points the other way. The ADA defines three levels of hypoglycaemia, and the third one requires another person.
Aug 6, 2026

The test everyone treats as the verdict measures sugar stuck to haemoglobin over the life of a red cell. Anything that changes how long those cells live changes the result, and several of those conditions are common across this region.
Jul 13, 2026

Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026

Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024

VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025

New research on mindful technology use reframes burnout as a work-design problem involving notifications, norms and control, not just an employee resilience problem.
Jul 24, 2026

A new 2026-2027 plan targets malnutrition, preventable blindness, heart care and essential treatment for nearly 50,000 people in Somalia.
Jul 29, 2026

Two individualized antisense treatments reduced the effects of a rare SCN2A disorder. The results are hopeful, but they come from two carefully monitored patients, not a broad trial.
Aug 1, 2026
